Moderna, Inc.
Close on Nov 2, 2026Market cap $88.16BP/E –Yield –
Moderna Infectious disease / prophylactic vaccines R&D by Year
Infectious disease / prophylactic vaccines R&D ($M) ($M)
Moderna Infectious disease / prophylactic vaccines R&D: $652M in FY2025, down 49.7% from a year earlier.
Where the FY2025 figure comes from
“Infectious disease vaccines | $ | 652 | $ | 1,297 | $ | 1,903”
Source: FY2025 10-K ↗
Reported in Form 10-K / 10-Q Item 7 (MD&A R&D Program Breakdown).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Infectious disease / prophylactic vaccines R&D ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 652 | -49.7% | FY2025 10-K ↗ |
| FY2024 | Dec 31, 2024 | 1,297 | -31.8% | FY2025 10-K ↗ |
| FY2023 | Dec 31, 2023 | 1,903 | +9.7% | FY2025 10-K ↗ |
| FY2022 | Dec 31, 2022 | 1,734 | +57.8% | FY2022 10-K ↗ |
| FY2021 | Dec 31, 2021 | 1,099 | +55.4% | FY2022 10-K ↗ |
| FY2020 | Dec 31, 2020 | 707 | +1,372.9% | FY2022 10-K ↗ |
| FY2019 | Dec 31, 2019 | 48 | +88.9% | FY2021 10-K ↗ |
| FY2018 | Dec 31, 2018 | 25.4 | – | FY2020 10-K ↗ |
Breakdown
What makes up infectious disease / prophylactic vaccines R&D
Cite this data
StockData. (2026). Moderna Infectious disease / prophylactic vaccines R&D ($M), annual FY2018–FY2025 [Data set]. Compiled from Moderna SEC filings and investor materials. https://stockdatahq.com/stocks/mrna/kpis/rd-infectious-vaccines
See every metric in the Moderna KPI table. Data updated Nov 3, 2026.